Clinical Trial Update: HLX07 Combination Therapy or Motherapy in Patient With Advanced Hepatocellular Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for HLX07 combination therapy in patients with advanced hepatocellular carcinoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatocellular Carcinoma

Drugs mentioned

• HLX07 (HLX07)

Snippet

Sponsor: Shanghai Henlius Biotech | Conditions: Advanced Hepatocellular Carcinoma | Phase 2 | Status: UNKNOWN